Found: 6
Select item for more details and to access through your institution.
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 5, p. 651, doi. 10.1007/s00401-023-02566-0
- By:
- Publication type:
- Article
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 3, p. 565, doi. 10.1007/s00401-022-02464-x
- By:
- Publication type:
- Article
Development and Characterisation of a Glutamate-Sensitive Motor Neurone Cell Line.
- Published in:
- Journal of Neurochemistry, 2000, v. 74, n. 5, p. 1895, doi. 10.1046/j.1471-4159.2000.0741895.x
- By:
- Publication type:
- Article
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18070-y
- By:
- Publication type:
- Article
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics.
- Published in:
- Neuropathology & Applied Neurobiology, 2021, v. 47, n. 6, p. 736, doi. 10.1111/nan.12716
- By:
- Publication type:
- Article
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 1, p. 153, doi. 10.1093/neuonc/noab178
- By:
- Publication type:
- Article